MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 48 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395 | -63.9% | 3,040 | 0.0% | 0.00% | – |
| Q2 2023 | $1,094 | -23.4% | 3,040 | 0.0% | 0.00% | – |
| Q1 2023 | $1,429 | -6.0% | 3,040 | 0.0% | 0.00% | – |
| Q4 2022 | $1,520 | -24.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 3,040 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -100.0% | 3,040 | -50.0% | 0.00% | – |
| Q1 2021 | $6,384,000 | +159500.0% | 6,080 | +100.0% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 3,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,923,000 | $509,990 | 0.12% |
| Arkadios Wealth Advisors | 1,399,000 | $181,870 | 0.02% |
| NEVILLE RODIE & SHAW INC | 1,157,332 | $150 | 0.01% |
| Platform Technology Partners | 162,410 | $21,113 | 0.01% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $101 | 0.01% |
| Main Street Financial Solutions, LLC | 400,826 | $52,107 | 0.01% |
| National Wealth Management Group, LLC | 42,750 | $5,558 | 0.01% |
| STALEY CAPITAL ADVISERS INC | 400,000 | $52,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 754,732 | $98,115 | 0.00% |
| HYMAN CHARLES D | 79,800 | $10,000 | 0.00% |